Cardiology News - congenital heart defects, coronary artery disease, heart failure, valvular heart disease, electrophysiology.

Cardiology News - congenital heart defects, coronary artery disease, heart failure, valvular heart disease, electrophysiology.

January 7, 2020 Risk for blood clots increased with PICC placement in children (HealthDay)—Central venous catheter (CVC) placement with peripherally inserted central catheters (PICCs) in children is associated with increased risks for venous thromboembolism (VTE), central line-associated bloodstream infection (CLABSI), and CVC malfunction, according to a study published online Jan. 7 in Blood . Julie Jaffray, M.D., from the Children's Hospital Los Angeles, and colleagues enrolled patients aged 6 months to 18 years with newly placed PICCs or tunneled lines (TLs) and compared the incidence of VTE in a multicenter prospective, observational cohort study. Data were included for 1,967 CVCs placed in 1,742 unique individuals. The researchers found that the incidence of catheter-related VTE was 5.9 ± 0.63 percent. Eighty percent of cases were in individuals with PICCs, which had a significantly higher risk for catheter-related VTE compared with TLs (hazard ratio, 8.5). Compared with those with TLs, patients with PICCs were also significantly more likely to have a CLABSI (hazard ratio, 1.6) and CVC malfunction (hazard ratio, 2.0). Patients with a prior history of VTE, multilumen CVC, and leukemia had an increased risk for CVC-related VTE (hazard ratios, 23. 3.9, and 3.5, respectively). "Now we can say definitively that patients who have PICCs have a much higher rate of thrombosis as well as central line associated bloodstream infections and catheter malfunctions when compared to TLs," Jaffray said in a statement. "PICCs are not as benign as we once thought." Explore further



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More